J. Romero

The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease.

Katherine K. Kim, R. DeBiasi, J. Newburger, 2019, Contemporary clinical trials.

Enteroviral Meningitis

J. Romero, K. Frenia, T. V. Parasuraman, 2012, PharmacoEconomics.

Enteroviral meningitis. Cost of illness and considerations for the economic evaluation of potential therapies.

J. Romero, K. Frenia, T. V. Parasuraman, 2001, PharmacoEconomics.

High delayed mortality after the first episode of Clostridium difficile infection.

A. Muriel, A. Royuela, M. Salavert, 2019, Anaerobe.

Comparative Effectiveness of Echinocandins vs Triazoles or Amphotericin B Formulations as Initial Directed Therapy for Invasive Candidiasis in Children and Adolescents.

Rachael K. Ross, M. Ardura, A. Localio, 2021, Journal of the Pediatric Infectious Diseases Society.

Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score.

M. Salavert, S. Cuéllar, C. Henriquez-Camacho, 2017, International journal of antimicrobial agents.

Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score.

M. Salavert, S. Cuéllar, C. Henriquez-Camacho, 2017, International journal of antimicrobial agents.